Results 11 to 20 of about 40,011 (243)

Diagnostic accuracy of interferon-gamma release assays for diagnosis of smear-negative pulmonary tuberculosis: a systematic review and meta-analysis [PDF]

open access: yesBMC Pulmonary Medicine, 2022
Introduction The diagnosis of smear-negative pulmonary tuberculosis (SNPTB) is challenging. Interferon gamma-release assays (IGRAs) may be helpful in early diagnosis among these patients resulting in prompt treatment and favorable outcomes.
Tananchai Petnak   +8 more
doaj   +2 more sources

Diagnostic Value of Interferon-Gamma Release Assays Combined with Multiple Indicators for Tuberculous Peritonitis [PDF]

open access: yesGastroenterology Research and Practice, 2020
Objective. To investigate the diagnostic value of interferon-gamma release assays combined with multiple indicators for tuberculous peritonitis. Methods.
Xidong He   +5 more
doaj   +2 more sources

Boosting effect of IL-7 in interferon gamma release assays to diagnose Mycobacterium tuberculosis infection. [PDF]

open access: yesPLoS ONE, 2018
BACKGROUND:A quarter of the world's population is estimated to be infected with Myobacterium tuberculosis (Mtb). Infection is detected by immune response to M.
Hellen Hiza   +9 more
doaj   +2 more sources

Evaluation of Diagnostic Performance of Three Commercial Interferon-Gamma Release Assays for Mycobacterium tuberculosis [PDF]

open access: yesDiagnostics
Interferon-gamma release assays (IGRAs) have gained attention for the diagnosis of latent tuberculosis infection (LTBI) due to their higher specificity compared to the tuberculin skin test (TST).
Richard Kutame   +8 more
doaj   +2 more sources

Comparison of Two Interferon-Gamma Release Assays for Pediatric Tuberculosis Infection. [PDF]

open access: yesJ Pediatric Infect Dis Soc
Abstract Introduction Identifying tuberculosis infection (TBI) using interferon-gamma release assays (IGRAs) is a primary component of clinical and public health efforts to prevent pediatric tuberculosis (TB). Pediatric data comparing the 2 IGRAs in the United States are very limited.
Gaensbauer JT   +4 more
europepmc   +3 more sources

Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study

open access: yesHealth Technology Assessment, 2018
Background: Despite a recent decline in the annual incidence of tuberculosis (TB) in the UK, rates remain higher than in most Western European countries.
Ibrahim Abubakar   +13 more
doaj   +2 more sources

Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation

open access: yesHealth Technology Assessment, 2019
Background: Interferon gamma release assays (IGRAs) are blood tests recommended for the diagnosis of tuberculosis (TB) infection. There is currently uncertainty about the role and clinical utility of IGRAs in the diagnostic workup of suspected active TB ...
Yemisi Takwoingi   +13 more
doaj   +2 more sources

Interferon Gamma Release Assays in Patients with Respiratory Isolates of Non-Tuberculous Mycobacteria – a Preliminary Study [PDF]

open access: yesPolish Journal of Microbiology, 2019
Augustynowicz-Kopeć E   +9 more
doaj   +2 more sources

Humoral and Cellular Immunity to Severe Acute Respiratory Syndrome Coronavirus-2 Vaccination in Patients with Sarcoidosis

open access: yesBalkan Medical Journal, 2023
Background: The coronavirus disease 2019 vaccine induces both antibody and T-cell immune responses and has been proven to be effective in preventing coronavirus disease 2019, including its severe disease form, in healthy individuals. However, the details
Ersan Atahan   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy